43
Participants
Start Date
April 2, 2024
Primary Completion Date
July 23, 2025
Study Completion Date
February 29, 2028
ALXN1850
ALXN1850 will be administered via subcutaneous (SC) injection.
asfotase alfa
Asfotase alfa will be administered via SC injection.
Research Site, South Brisbane
Research Site, Baltimore
Research Site, Edirne
Research Site, Erzurum
Research Site, Durham
Research Site, Istanbul
Research Site, Nashville
Research Site, Minneapolis
Research Site, Kansas City
Research Site, Hartford
Research Site, Mar del Plata
Research Site, Ottawa
Research Site, Bunkyō City
Research Site, Minatoku
Research Site, Suita-shi
Research Site, Yonago-shi
Research Site, Altındağ
Research Site, Ankara
Research Site, Birmingham
Research Site, Manchester
Research Site, Sheffield
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY